WO1999063907A1 - Vessel occlusive apparatus and method - Google Patents
Vessel occlusive apparatus and method Download PDFInfo
- Publication number
- WO1999063907A1 WO1999063907A1 PCT/US1999/012624 US9912624W WO9963907A1 WO 1999063907 A1 WO1999063907 A1 WO 1999063907A1 US 9912624 W US9912624 W US 9912624W WO 9963907 A1 WO9963907 A1 WO 9963907A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- occlusive
- vessel
- plunger
- occlusive member
- occluding
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 21
- 230000007246 mechanism Effects 0.000 claims abstract description 46
- 239000012530 fluid Substances 0.000 claims abstract description 24
- 210000003708 urethra Anatomy 0.000 claims description 36
- 230000003187 abdominal effect Effects 0.000 claims description 21
- 230000008901 benefit Effects 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 16
- 230000035558 fertility Effects 0.000 claims description 5
- 210000003899 penis Anatomy 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 5
- 210000000013 bile duct Anatomy 0.000 claims description 4
- 210000004204 blood vessel Anatomy 0.000 claims description 4
- 208000034347 Faecal incontinence Diseases 0.000 claims description 3
- 239000013536 elastomeric material Substances 0.000 claims description 3
- 210000003101 oviduct Anatomy 0.000 claims description 3
- 210000001177 vas deferen Anatomy 0.000 claims description 3
- 230000008602 contraction Effects 0.000 claims description 2
- 239000000560 biocompatible material Substances 0.000 claims 1
- 210000003462 vein Anatomy 0.000 claims 1
- 210000003932 urinary bladder Anatomy 0.000 description 13
- 230000002485 urinary effect Effects 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 9
- 229920002379 silicone rubber Polymers 0.000 description 7
- 230000000994 depressogenic effect Effects 0.000 description 6
- 238000002513 implantation Methods 0.000 description 6
- 210000003739 neck Anatomy 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 5
- 210000005070 sphincter Anatomy 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 238000010276 construction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 241001313288 Labia Species 0.000 description 3
- 208000002847 Surgical Wound Diseases 0.000 description 3
- 241001422033 Thestylus Species 0.000 description 3
- 206010046543 Urinary incontinence Diseases 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036724 intravesical pressure Effects 0.000 description 3
- 230000004118 muscle contraction Effects 0.000 description 3
- 210000004706 scrotum Anatomy 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 206010021639 Incontinence Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 229910000756 V alloy Inorganic materials 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010073 coating (rubber) Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000003689 pubic bone Anatomy 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
- A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/25—Artificial sphincters and devices for controlling urinary incontinence
Definitions
- the present invention relates to an apparatus and method for occluding fluid conveying vessels in the body.
- the present invention relates to an apparatus and method to replace the absent or damaged sphincteric function of a variety of bodily organs.
- the present invention has particular use for occluding the urethra so as to restore urinary continence to patients with urinary control problems.
- Other areas of application of the present invention include, but are not limited to, the gastroesophageal sphincter and rectal sphincter in both men, women and children.
- Urinary incontinence is a frequent and distressing sequel to various neurological diseases, surgical procedures, spinal cord injury, etc.
- Various urethral occlusive devices have been developed in an effort to restore urinary continence to patients with urinary control problems.
- the present invention offers a substantial improvement over existing vessel occlusive apparatus and methods.
- the present invention relates to an occlusive apparatus and method for reversibly occluding fluid conveying vessels in the body.
- the present invention has numerous applications for controlling and/or occluding fluid flow in the fluid conveying vessels in humans and/or animals. Its applications include control of fecal incontinence, venous outflow from a penis thereby controlling impotence, bile duct flow, male and female fertility, blood flow in blood vessels, etc.
- the present invention can be used in conjunction with most any vessel in the body. In many applications, the present invention will occlude the vessel as required to stop or prohibit fluid flow. In other applications, the present invention will control the amount of fluid flow through the vessel.
- an occlusive apparatus for reversibly occluding a fluid conveying vessel.
- the occlusive apparatus includes an occlusive member adapted for at least partially encircling the vessel, with the occlusive member including an intrinsic spring force therein for exerting an occluding pressure on the vessel while the occlusive member at least partially encircles the vessel.
- a control mechanism is operatively connected to the occlusive member, with the control mechanism being arranged and configured to counteract the intrinsic spring force of the occlusive member and thereby remove the occluding pressure on the vessel while the occlusive member is at least partially encircling the vessel.
- an apparatus for reversibly occluding a fluid conveying vessel includes an occlusive member adapted for at least partially encircling the vessel, with the occlusive member including an intrinsic resilient biasing force which biases the occlusive member to a contracted state for exerting an occluding pressure on the vessel while the occlusive member at least partially encircles the vessel.
- a control mechanism is operatively connected to the occlusive member for actuating the occlusive member to an expanded state.
- the control mechanism is arranged and configured to counteract the intrinsic resilient biasing force of the occlusive member and thereby force the occlusive member to the expanded state and remove the occluding pressure on the vessel while the occlusive member is at least partially encircling the vessel.
- the occlusive member is in the form of a loop or ring, which exerts a predetermined, radial pressure evenly about the vessel sufficient to prevent fluid flow through the vessel. The radial pressure is removed by the control mechanism to allow unobstructed flow through the vessel.
- the occlusive member is in the form of a sling which underlies the vessel for occluding flow through the vessel.
- the control mechanism is utilized to lower the sling, thereby allowing unobstructed flow through the vessel.
- an expandable and contractable member is adapted for at least partially encircling a body vessel, with the member including an intrinsic resilient biasing force which biases the member to a contracted state.
- An abdominal pressure sensor adapted for sensing abdominal pressure is provided for providing inputs to a control mechanism that is operatively connected to said member.
- the control mechanism is arranged and configured to control expansion and contraction of the member in response to the abdominal pressure sensed by the abdominal pressure sensor.
- a method for controlling fluid flow in a fluid conveying vessel includes the steps of surrounding at least a portion of the vessel with a member that is resiliently biased to a contracted state such that an occluding pressure is exerted on the vessel when the member is in the contracted state, and selectively forcing the member to an expanded state thereby at least partially removing the occluding pressure on the vessel.
- the occlusive apparatus of the present invention Since the occlusive apparatus of the present invention is of unitary construction, it does not require intra-operative connection of components. Previous occlusive devices have required multiple components to be connected together by the surgeon, which increase the intra-operative time and fatigue, with a risk of component disconnection after implantation.
- the occlusive apparatus of the present invention does not have to be filled with liquid as previous devices have required. This saves on intra- operative time and the potential for fluid leakage in the event of a disconnection or device fatigue is eliminated.
- the occlusive member of the present invention is also narrower than current devices utilizing hydraulic cuffs. It is believed that this reduction in width reduces the amount of tissue dissection to implant the member, while achieving the same occlusive pressure as the larger width devices, thereby reducing the tendency for the vessel to atrophy or erode. Further, previous hydraulic urethral cuffs have tended to form folds and pillows when encircling the urethra.
- the occlusive member in one embodiment of the present invention encircles the urethra in a circular fashion and applies pressure to the urethra evenly over its entire circumference. This reduces the risk of urethral erosion and increases the occlusive efficiency.
- Figure 1 is a perspective view of an occlusive apparatus in accordance with the principles of the present invention
- Figures 2A and 2B are side elevational views of the occlusive apparatus shown in Figure 1 , in an activated condition and a deactivated condition, respectively;
- Figure 3 is a diagrammatic view of the occlusive member which forms a portion of the occlusive apparatus, which illustrates how the ends of the occlusive member are connected together;
- Figures 4A and 4B are diagrammatic views of another embodiment of the occlusive apparatus of the present invention in which the occlusive member forms a sling for the vessel, with Figure 4A illustrating the activated condition and Figure 4B illustrating the deactivated condition;
- Figures 5A and 5B are diagrammatic views showing the embodiment of Figures 4A and 4B, respectively, interacting with a urethra; and
- Figure 6 is a diagrammatic view of still another embodiment of the occlusive apparatus in accordance with the present invention which is configured for automated operation.
- Figure 7 is a side view of an alternate actuator for the occlusive member which provides a mechanical advantage.
- Figure 8 is a cross-sectional view taken along line 8-8 of Figure 7.
- Figure 9 is a side view of yet another alternate embodiment of an actuator.
- Figure 10 is a side view of another embodiment of the actuator.
- the apparatus and method of the present invention might be utilized in conjunction with any number of different vessels in humans and animals which are used to convey fluid.
- the following are some examples of various applications of the present invention, however this list is by no means exhaustive of the numerous applications in which the present invention may be used.
- the occluding apparatus of the present invention might be used to control fecal incontinence or bowel movements, to control venous outflow from a penis and thus control impotence, to control bile duct flow, to control fluid flow in the vas deferens and thus male fertility, to control fluid flow in the fallopian tubes and thus control female fertility, to control blood flow in blood vessels for vascular studies or the like, etc.
- a urethral occlusive apparatus in accordance with the present invention in the preferred embodiment is designed to be totally implantable into a body.
- the apparatus has no tubes or wires or other electro-mechanical connection passing through the skin. Additionally, in the preferred embodiment, no external appliances are required to operate the occlusive apparatus. However, coupled coils might be used either for continuous powering of the device or to recharge batteries which are implanted to power the apparatus, when the apparatus is automated.
- the occlusive apparatus of the present invention has a unitary construction and may be implanted into the patient through a single surgical incision. Further, the occlusive apparatus of the present invention is of unitary construction, and does not require intra-operative connection of components.
- the occlusive apparatus of the present invention is also designed to accommodate a larger range of vessel diameters and changes in vessel diameters.
- the urethral occlusive apparatus is made of materials, as well as having a geometric configuration, which is compatible with the body. Suitable materials used might include implantable grade polymeric materials, titanium and titanium alloys, and stainless steels. Preferably, all surfaces in contact with body fluids and/or tissues meet the required, e.g. class 6 U.S. P., tests for toxicity and pyrogenicity. In addition, corners and edges are rounded and surfaces are nonabrasive to body structures.
- the urethral apparatus of the present invention is also lightweight so as to minimize any chance for migration. In the preferred embodiment, the operation of the urethral occlusive apparatus is easily understood and readily controlled by the user requiring a minimal amount of manual or mental dexterity.
- control mechanism of the urethral apparatus shall be of a size to be readily grasped by the user.
- control mechanism may be electro-mechanically controllable or controlled by other wireless means such as batteries, coupled coils or radio frequency (RF) signals.
- the occlusive force exerted against the urethra shall be sufficient to prevent urinary leakage, but not so great that the urethral viability is impaired.
- the pressure shall not exceed 100 cm H 2 O for more than 10 minutes when in the activated state.
- the urethral occluding apparatus shall not interfere with urine flow when in the expanded or deactivated state.
- Alternate embodiments of the urethral occluding apparatus shall have automatic occluding pressure release capabilities with high intra-vesical pressure.
- a detrusor muscle contraction bladedder muscle contraction
- an intra-vesical pressure greater than 120 cm H 2 O estimated normal voiding pressure
- a non-functioning urethral occluding apparatus of the present invention shall leave the patient in his/her preimplant incontinent condition.
- the device shall be inert to the presence of body tissues, and materials forming the occluding apparatus shall be of an implantable quality and be non-allergenic to the patient.
- the occluding apparatus will prevent leakage during coughing, straining or other sudden increases in abdominal pressure.
- a preferred embodiment of the occluding apparatus shall contain a sensor to be placed in the abdominal cavity to feed back pressure information to a controller.
- the sensor senses intra- abdominal, extravesical pressure that causes intra-vesical pressure (i.e. bladder pressure) to rise without a detrusor muscle contraction. When this occurs in the presence of impaired urinary sphincter contractibility, urinary incontinence occurs.
- a sensor could also be provided to sense neural impulses related to detrusor muscle activity and cause the urethral occluding apparatus to respond appropriately.
- Preferably materials used in the system shall not deteriorate in contact with body fluids and tissue so as to provide the occluding apparatus with long-term usage.
- the maximum obtainable pressure in the activated condition of the occluding apparatus shall be inherent and therefore not dependent upon the ability of the user to manipulate the apparatus.
- the occluding apparatus 10 includes an occlusive member 12 in the form of a loop that is movable between a contracted, activated condition as shown in Figure 2A and an expanded, de-activated condition as shown in Figure 2B.
- the occlusive member 12 encircles the urethra 14 in males (or the bladder neck in females and young males) and exerts a predetermined, radial occluding pressure evenly about the urethral or bladder neck circumference when in the contracted condition.
- This occluding pressure is sufficient to prevent urine leakage during events where the bladder pressure is increased, for instance due to coughs, sneezes, sporting activities, etc.
- the occlusive member 12 is moved to the expanded, de-activated condition, unobstructed urinary drainage is allowed.
- the occlusive member 12 is constructed to have an intrinsic radial spring or biasing force therein which radially biases the occlusive member 12 to the contracted condition.
- the occlusive member 12 is normally biased to the contracted condition, shown in Figure 2A, and exerts an occluding pressure on the urethra 14 to prevent urine flow.
- the biasing force in the occlusive member 12 must be removed or counteracted by forcing the occlusive member 12 to the expanded or stretched condition shown in Fig. 2B.
- the occlusive member 12 is constructed from an expandable and compressible material, such as expanded polytetraflouroethylene (ePTFE), which in its compressed state, is coated with an elastomeric material, such as silicon rubber. Therefore, any expansion or stretching of the ePTFE substrate will cause the elastomeric silicone rubber coating to stretch in a manner equivalent to that of a constant force spring. It is this force that forms the intrinsic biasing force of the occlusive member 12, thereby biasing the occlusive member to the contracted condition and imparting the occlusive pressure to the urethra.
- ePTFE expanded polytetraflouroethylene
- the occlusive member 12 is designed to accommodate a wide range of urethra and bladder neck sizes, such as urethras with circumferences ranging from about 3.5 cm. to about 6.0 cm., or bladder necks with circumferences ranging from about 6.0 cm. to about 12.0 cm., and the occlusive member 12 has a reduced width, such as a width of approximately 1.0 cm.
- the occlusive pressure of the occlusive member 12 may be manually removed by the patient, i.e. the occlusive member 12 is forced to the expanded condition of Fig. 2B, to allow unobstructed urinary flow.
- the occluding apparatus 10 includes a control mechanism 16 which is joined to the occlusive member 12 for counteracting the biasing force of the occlusive member to force the occlusive member to the expanded condition.
- the control mechanism 16 includes an actuator 18, a conduit tube 20 joining the occlusive member 12 and the actuator 18, and an elongate wire member 22 that is connected at one end to the actuator 18 and extends through the conduit tube 20 and the occlusive member 12 where the wire 22 is fixed at its opposite end.
- the actuator 18, which is implanted in the scrotum of a male or the labia of a female, is manually manipulated by the patient, to apply a pushing force to the wire 22 so as to advance the wire through the conduit tube 20. Since one end of the wire 22 is fixed in the occlusive member 12, advancement of the wire by the actuator 18 causes the occlusive member to expand or stretch, thereby removing the occluding pressure.
- the conduit tube 20 is extruded from a polymeric material, such as ePTFE similar that used for the occlusive member 12, and is connected at one end thereof to the occlusive member 12 by a shroud 24 and connected at its opposite end to a flexible, silicon rubber boot 26 encasing the actuator 18.
- the ePTFE material of the tube 20, in its fully stretched state, is coated with silicon rubber 21. Thus, the ePTFE material is not free to stretch in this condition and therefore does not act like a spring.
- the silicon rubber layer 21 of the conduit tube 20 is intended to prevent tissue ingrowth that may occur during tissue healing after surgery to implant the occluding apparatus 10, to facilitate adhesive bonding between the shroud 24 and the boot 26, improve kink resistance of the tube 20, and to prevent influx of bodily fluids into the inner cavities of the apparatus 10.
- the ePTFE material of the conduit tube 20 also provides a low friction surface over which the wire 22 can travel, as well as minimizing stretching of the tube 20.
- the conduit tube 20 is suitably dimensioned for disposition within the body.
- the conduit tube measures about 6 to about 10 inches in length, and has an outside diameter of about 0.15 inches. Other tube dimensions could be used however, depending upon the size of the patient the apparatus 10 is to be used in.
- the wire 22 is connected at one end to the actuator 18, extends through the conduit tube 20 and through the occlusive member 12, and is attached at its second end to a clip 28 that forms a portion of the occlusive member 12. It is the wire 22 that transmits force to the occlusive member 12, when actuated by the actuator 18, so as to counteract the intrinsic biasing force of the occlusive member and force the occlusive member to the expanded condition. As the wire 22 is advanced by the actuator 18, the wire loop within the occlusive member 12 increases in diameter thereby forcing the occlusive member 12 to increase in diameter as well, so as to remove the occluding pressure from the urethra 14.
- the wire 22 is manufactured from a suitable implant grade material having elastic properties to minimize permanent kinking of the wire which may occur when the conduit tube 20 is flexed during implantation or when the conduit tube 20 and occlusive member 12 are flexed by forces applied during normal activity of the patient.
- a suitable material for the wire is a nickel titanium alloy having superelastic properties. Other materials could be used as well.
- the actuator 18, which is encased within the flexible silicon rubber boot 26, is implanted in the scrotum of a male or the labia of a female, and allows the patient to manually actuate the occlusive member 12 to the expanded condition.
- the actuator 18 can measure about 5.0 cm x 1.2 cm x 1.0 cm to allow implantation, however other actuator sizes can be used as well, as long as the actuator can be implanted into the intended area.
- the rubber boot 26, as illustrated in Figure 1 is disposed around the actuator 18 and is intended to allow actuation of the actuator while preventing tissue ingrowth and ingress of bodily fluids into the actuator.
- the boot 26 includes a bellows portion 30 which facilitates actuation of the actuator 18.
- the actuator 18 includes an actuator housing 32 to which one end of the conduit tube 20 is attached.
- the housing 32 includes a central bore 34 in which is slideably received a plunger 36, with one end of the wire 22 being suitably fastened to the plunger 36.
- the plunger 36 is freely slideable within the bore 34 of the housing 32 between an activated position shown in Figure 2A and a deactivated position shown in Figure 2B.
- the wire 22 and plunger 36 are forced by the intrinsic biasing force of the occlusive member 12 to the activated position so that the plunger 36 extends substantially past the end of the housing 32 ready to be actuated by the patient.
- a locking mechanism is provided to lock the plunger 36 at the deactivated position, so as to allow unobstructed voiding by the patient and to remove the occlusive force of the occlusive member 12 during the post surgical healing period.
- the locking mechanism includes a lever 38 that is pivotally connected to the housing 32 by a pin 40, so that the lever 38 is able to pivot about the axis of the pin 40.
- One end 42 of the lever 38 extends outside of the housing 32 and the other end 44 of the lever extends through the housing and into the bore 34.
- the end 44 of the lever 38 includes an inwardly extending detent shoulder 46 thereon, and the end of the plunger 36 includes a circumferential detent groove 48 formed therein.
- the lever 38 is biased in a counterclockwise direction about the axis of the pin 40 by a resilient o-ring 50 disposed around the housing 32 and the end 44 of the lever.
- the end of the plunger 36, forward of the detent groove 48, has a conic or frusto-conic surface 52, which engages the detent shoulder 46 as the plunger 36 is moved to the deactivated position.
- the engagement between detent shoulder 46 and the surface 52 forces the lever 38 to pivot clockwise, against the bias of the o- ring 50, until the plunger 36 is moved to a position where the detent shoulder 46 drops into the detent groove 48 and is maintained therein by the bias of the o-ring 50.
- the plunger 36 is thus locked at the deactivated position, with the occlusive member 12 maintained at the expanded condition.
- the patient locates the portion of the boot 26 overlying the lever 38 and simply presses the end 42 of the lever 38 downward, thereby lifting the detent shoulder 46 out of the detent groove 48, which allows the intrinsic biasing force of the occlusive member 12 to force the wire 22 and plunger 36 back to the activated position.
- the housing 32, plunger 36 and lever 38 may be manufactured from an implant grade titanium material, such as wrought Titanium-6 Aluminum-4 Vanadium alloy, or a semi-rigid thermoplastic material, such as polysulfone.
- the occlusive member 12 of the occlusive apparatus 10 is packaged and ready for implantation within the patient in a non-loop, open state.
- the occlusive member 12 is specifically designed to allow formation of the occlusive member 12 into a loop.
- the clip 28 is disposed at one end of the occlusive member 12.
- the clip 28 includes a pull tab 54 attached thereto which allows a surgeon to pull the occlusive member through a pocket that has been dissected around the urethra or bladder neck.
- the pull tab 54 is inserted into a hole formed through the shroud 24 that joins the occlusive member 12 and the conduit tube 20, and the pull tab 54 is pulled through the shroud.
- the occlusive member 12 begins to form a ring around the urethra.
- the clip 28, which is formed with a hook 56 eventually reaches the shroud 24, at which point the hook 56 extends into the hole in the shroud 24 and the area of the clip between the hook 56 and the rest of the clip 28 clips onto the shroud 24, thereby locking the occlusive member 12 into an encircling position around the urethra 14.
- the exposed end of the pull tab 54 is then trimmed away by the surgeon.
- Figures 4A and 4B illustrate another embodiment of the invention wherein the occlusive member 12' is in the form of a U-shaped sling which underlies the urethra or bladder neck 14.
- One end 60 of the occlusive member 12' is attached to a pubic bone structure 62 in the patient on one side of the urethra 14.
- the occlusive member 12' extends underneath the urethra 14 and back upwards toward the bone structure 62, where the occlusive member 12' connects to the conduit tube 20, and where the occlusive member 12' and the conduit tube 20 are attached to the bone structure 62 on the other side of the urethra.
- the intrinsic biasing force of the occlusive member 12' causes the occlusive member 12' to be contracted, thereby reducing the overall length of the occlusive member 12' which elevates the sling so that the urethra is raised upward from its normal position.
- Figure 5 A shows the urethra 14 and bladder 64, with the urethra elevated by the sling. Elevation of the urethra 14 bends or kinks the urethra, causing occlusion to occur.
- the occlusive member 12' is caused to expand or stretch to the deactivated position, shown in Figure 4B.
- Expansion or stretching of the occlusive member 12' increases its length, thereby increasing the size of the "U” formed by the occlusive member 12', which lowers the urethra back to its normal anatomical position to allow unobstructed urinary flow.
- the lowered position of the urethra at the deactivated condition can also be seen in Figure 5B.
- FIG. 6 illustrates yet another embodiment of the invention, in which operation of the occlusive apparatus 10 is automatically controlled.
- the control mechanism 16 of this embodiment replaces the actuator 18 with a driver 68 that is operatively coupled to the wire member 22 for controlling operation of the apparatus 10.
- the driver 68 which can be an electric motor or other suitable electrically powered motor, preferably includes a power source, such as a battery or batteries, which supplies power to the driver. Alternatively, the driver 68 could be connected to externally supplied power outside the patient.
- the driver 68 preferably includes a driver controller that is integral therewith for controlling the operation of the driver.
- An abdominal pressure sensor 70 is electrically connected to the driver 68 for providing inputs to the driver controller of the driver.
- the pressure sensor 70 is preferably placed in the pre-vesical space next to the urinary bladder to sense intra-abdominal pressure and send signals representative of the sensed pressure to the driver controller of the driver 68.
- the occluding apparatus 10 is activated by the driver 68 according to a predetermined algorithm or preprogrammed logic within the driver controller.
- the algorithm provides for the apparatus 10 to be forced to the de-activated, non-occluding position when the sensed pressure is less than resting bladder pressure of approximately 20 cm H 2 O.
- intra-abdominal pressure exceeds 20 cm H 2 O, the apparatus 10 is returned to the activated, occluding position to prevent urinary leakage.
- the driver controller might include interface capability for interconnection to various peripherals, including an adapter/charger which might be plugged into an AC outlet by a suitable power cord for powering the driver 68 or recharging the driver battery.
- the interconnection might be accomplished by coupled transformer coils or other suitable methods.
- the interconnection might also provide for external resetting and/or modification of the predetermined algorithm. Use of interconnection methods such as coupled transformer coils will allow the interface to be accomplished preferably without the use of wires or other physical connectors extending through the skin. It will be appreciated that this embodiment will preferably include program logic which can be readily programmed for different parameter settings, functions, etc. both before implantation of the occlusive apparatus 10 or after implantation.
- Figures 7 and 8 show an alternate embodiment of an actuator 72 that can be used to apply a pushing force to the wire member 22, thereby counteracting the biasing force of the occlusive member 12 to force the occlusive member to the expanded condition.
- the actuator 72 includes a housing 74 having a central chamber 76 in which is rotatably mounted a mechanical advantage mechanism 78.
- the mechanical advantage mechanism 78 includes a spool 80 which is connected to the end of the wire member 22, and a pinion member 82 rigidly connected to the spool 80 and rotatable therewith.
- a plunger 84 having a rack 86 formed thereon slideably extends through the rear of the housing 74, with the rack 86 being in engagement with the pinion 82. As the plunger 84 is depressed, the rack 86 moves forward and drives the pinion 82 and the spool 80 counterclockwise. This advances the wire 22 forward, thereby forcing the occlusive member 12 to the expanded condition.
- the diameter of the spool 80 is larger than the diameter of the pinion 82 in order to amplify the movement of the plunger 84, such that the distance that the patient must depress the plunger 84 to deactivate the occlusive member 12 is reduced.
- the spool could have a diameter of about 0.375 inches while the diameter of the pinion could have a diameter of about 0.188 inches, such that if the plunger 84 is depressed a distance of about 1.5 cm, the wire 22 is advanced a distance of about 3.0 cm.
- the spool and pinion could have other diameters as well, as long as the movement of the plunger is amplified.
- the plunger 84 is also provided with a locking mechanism for locking the plunger at the deactivated position.
- the locking mechanism includes a stylus 88 which is biased into engagement with the plunger 84 on the side of the plunger opposite the rack 86 by a biasing spring 90.
- a stylus detent 92 is provided at the end of the plunger 84 which engages with the stylus 88 to lock the plunger at the deactivated position.
- the locking mechanism is constructed such that as the plunger 84 moves to the end of its depression stroke, the stylus 88 and detent 92 lock the plunger in the deactivated state.
- a further actuator 94 is illustrated in Figure 9, which is designed to reduce the size of the portion that is implanted within the scrotum or labia, as well as allowing a greater displacement magnification of the plunger.
- This embodiment includes a mechanical advantage mechanism 96 that is separate from a plunger 98.
- the mechanical advantage mechanism 96 includes a first, larger diameter spool 100 that is connected to the end of the wire 22 and a second, smaller diameter spool 102 that is rigidly connected to the first spool 100.
- the spools 100, 102 are rotatably mounted within a housing 104.
- a cable 106 is connected at one end thereof to the spool 102, and is connected at its opposite end to a spool 108 that is rotatably mounted within a plunger housing 110.
- the spool 108 is connected to a pinion 112 which is driven by a rack 114 formed on the plunger 98.
- a spring 116 extending between the housing 110 and the plunger 98 biases the plunger to the activated position.
- a locking mechanism including a stylus 88 and spring 90, similar to the locking mechanism of Figure 7, is also provided for locking the plunger 98 at the deactivated position.
- the rack 114 drives the spool 109 and pinion 112 clockwise, thereby tensioning or retracting the cable 106.
- the cable 106 retracts, it drives the spools 100, 102 counterclockwise thereby advancing the wire 22 to force the occlusive member 12 to the expanded condition.
- the intrinsic biasing force of the occlusive member 12 and the spring 116 contribute to force the components back to the activated condition.
- the actuator 118 of Figure 10 is similar to the actuator of Figure 9, including a separate mechanical advantage mechanism 120 and plunger 122.
- the mechanical advantage mechanism 120 includes a housing 124 in which are rotatably mounted a spool 126 connected to the wire member 22 and a pinion 128 connected to the spool 126 and rotatable therewith.
- a rack member 130 slidably extends through the housing 124 and engages with the pinion 128 for driving the spool 126 and pinion 128.
- a cable 132 is connected at one of its ends to the rack member 130 and connected at its opposite end to the plunger 122 which is slideably disposed within a plunger housing 134.
- a spring 136 disposed within the housing 134 biases the plunger 122 to the activated position.
- the plunger, plunger housing and/or the mechanical advantage housing are preferably encased within a silicon rubber boot, similar to the boot 26.
- the cables 106, 132 are preferably surrounded by a protective sheath similar to the tube 20, to allow sliding movements of the cables 106, 132 while preventing kinking of the cables, as well as preventing tissue ingrowth and ingress of bodily fluids.
Landscapes
- Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
- Prostheses (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99928412A EP1085841A1 (en) | 1998-06-09 | 1999-06-08 | Vessel occlusive apparatus and method |
CA002334387A CA2334387A1 (en) | 1998-06-09 | 1999-06-08 | Vessel occlusive apparatus and method |
JP2000552983A JP2002517277A (en) | 1998-06-09 | 1999-06-08 | Tube occlusion device and method |
AU45483/99A AU746023B2 (en) | 1998-06-09 | 1999-06-08 | Vessel occlusive apparatus and method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/094,055 US6074341A (en) | 1998-06-09 | 1998-06-09 | Vessel occlusive apparatus and method |
US09/094,055 | 1998-06-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999063907A1 true WO1999063907A1 (en) | 1999-12-16 |
Family
ID=22242584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/012624 WO1999063907A1 (en) | 1998-06-09 | 1999-06-08 | Vessel occlusive apparatus and method |
Country Status (7)
Country | Link |
---|---|
US (1) | US6074341A (en) |
EP (1) | EP1085841A1 (en) |
JP (1) | JP2002517277A (en) |
CN (1) | CN1305357A (en) |
AU (1) | AU746023B2 (en) |
CA (1) | CA2334387A1 (en) |
WO (1) | WO1999063907A1 (en) |
Cited By (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1257233A1 (en) * | 2000-02-24 | 2002-11-20 | BENDEREV, Theodore V. | Surgical monitor |
EP1582176A1 (en) * | 2000-02-10 | 2005-10-05 | Potencia Medical AG | Mechanical impotence treatment apparatus |
EP1586283A2 (en) | 2000-02-11 | 2005-10-19 | Potencia Medical AG | Urinary incontinence treatment apparatus |
EP1598030A1 (en) * | 2000-02-10 | 2005-11-23 | Potencia Medical AG | Controlled urinary incontinence treatment |
EP1609440A1 (en) * | 2000-02-10 | 2005-12-28 | Potencia Medical AG | Anal incontinence treatment apparatus with controlled energy supply |
EP1253888B1 (en) * | 2000-02-11 | 2006-01-11 | Potencia Medical AG | Anal incontinence treatment apparatus |
US7128750B1 (en) | 1999-07-19 | 2006-10-31 | Endoart S.A. | Flow control method and device |
EP1284691B1 (en) * | 2000-02-11 | 2006-12-20 | Potencia Medical AG | Urinary incontinence treatment apparatus |
EP1554996B1 (en) * | 1998-08-13 | 2008-01-16 | Obtech Medical AG | Food intake restriction device |
EP2002802A1 (en) * | 2007-06-15 | 2008-12-17 | Microval | Device for placing an implant made from flexible material under tension |
CN1698552B (en) * | 2000-02-10 | 2010-05-12 | 厄罗洛吉卡股份公司 | Controlled urinary incontinence treatment |
CN1720879B (en) * | 2000-02-10 | 2011-01-19 | 厄罗洛吉卡股份公司 | Urinary incontinence treatment with wireless energy supply. |
US7988616B2 (en) | 2002-10-01 | 2011-08-02 | Potencia Medical Ag | Implantable pump for operation of hydraulic implant |
US8715159B2 (en) | 2006-10-20 | 2014-05-06 | Ellipse Technologies, Inc. | Adjustable implant and method of use |
US8874215B2 (en) | 2008-10-10 | 2014-10-28 | Peter Forsell | System, an apparatus, and a method for treating a sexual dysfunctional female patient |
US8992409B2 (en) | 2007-10-11 | 2015-03-31 | Peter Forsell | Method for controlling flow in a bodily organ |
US9060771B2 (en) | 2008-01-29 | 2015-06-23 | Peter Forsell | Method and instrument for treating obesity |
US9351664B2 (en) | 2007-10-11 | 2016-05-31 | Peter Forsell | Implantable device for external urinary control |
US9662117B2 (en) | 2007-10-11 | 2017-05-30 | Peter Forsell | Apparatus for controlling flow in a bodily organ |
GB2545667A (en) * | 2015-12-21 | 2017-06-28 | Balatech Ltd | Flow control valves |
US9775709B2 (en) | 2011-11-04 | 2017-10-03 | Valtech Cardio, Ltd. | Implant having multiple adjustable mechanisms |
US9913774B2 (en) | 2007-10-11 | 2018-03-13 | Peter Forsell | Implantable device for external urinary control |
US9918840B2 (en) | 2011-06-23 | 2018-03-20 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US10238427B2 (en) | 2015-02-19 | 2019-03-26 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for vertebral adjustment |
US10265170B2 (en) | 2013-12-26 | 2019-04-23 | Valtech Cardio, Ltd. | Implantation of flexible implant |
US10271885B2 (en) | 2014-12-26 | 2019-04-30 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for distraction |
US10299793B2 (en) | 2013-10-23 | 2019-05-28 | Valtech Cardio, Ltd. | Anchor magazine |
US10349982B2 (en) | 2011-11-01 | 2019-07-16 | Nuvasive Specialized Orthopedics, Inc. | Adjustable magnetic devices and methods of using same |
US10350068B2 (en) | 2009-02-17 | 2019-07-16 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
US10349995B2 (en) | 2007-10-30 | 2019-07-16 | Nuvasive Specialized Orthopedics, Inc. | Skeletal manipulation method |
US10405891B2 (en) | 2010-08-09 | 2019-09-10 | Nuvasive Specialized Orthopedics, Inc. | Maintenance feature in magnetic implant |
US10492909B2 (en) | 2009-12-02 | 2019-12-03 | Valtech Cardio, Ltd. | Tool for actuating an adjusting mechanism |
US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US10517643B2 (en) | 2009-02-23 | 2019-12-31 | Nuvasive Specialized Orthopedics, Inc. | Non-invasive adjustable distraction system |
US10548729B2 (en) | 2009-05-04 | 2020-02-04 | Valtech Cardio, Ltd. | Deployment techniques for annuloplasty ring and over-wire rotation tool |
US10561498B2 (en) | 2005-03-17 | 2020-02-18 | Valtech Cardio, Ltd. | Mitral valve treatment techniques |
US10583234B2 (en) | 2008-10-10 | 2020-03-10 | Peter Forsell | Heart help device, system and method |
US10646262B2 (en) | 2011-02-14 | 2020-05-12 | Nuvasive Specialized Orthopedics, Inc. | System and method for altering rotational alignment of bone sections |
US10660675B2 (en) | 2010-06-30 | 2020-05-26 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10729470B2 (en) | 2008-11-10 | 2020-08-04 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10743794B2 (en) | 2011-10-04 | 2020-08-18 | Nuvasive Specialized Orthopedics, Inc. | Devices and methods for non-invasive implant length sensing |
US10751094B2 (en) | 2013-10-10 | 2020-08-25 | Nuvasive Specialized Orthopedics, Inc. | Adjustable spinal implant |
US10765504B2 (en) | 2017-12-01 | 2020-09-08 | C. R. Bard, Inc. | Adjustable vascular graft for custom inner diameter reduction and related methods |
US10835290B2 (en) | 2015-12-10 | 2020-11-17 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10918425B2 (en) | 2016-01-28 | 2021-02-16 | Nuvasive Specialized Orthopedics, Inc. | System and methods for bone transport |
US11191579B2 (en) | 2012-10-29 | 2021-12-07 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US11246694B2 (en) | 2014-04-28 | 2022-02-15 | Nuvasive Specialized Orthopedics, Inc. | System for informational magnetic feedback in adjustable implants |
US11938318B2 (en) | 2008-10-10 | 2024-03-26 | Peter Forsell | Apparatus for temporary male contraception |
Families Citing this family (242)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6454698B1 (en) * | 1999-08-12 | 2002-09-24 | Obtech Medical Ag | Anal incontinence treatment with energy transfer device |
US6471635B1 (en) * | 2000-02-10 | 2002-10-29 | Obtech Medical Ag | Anal incontinence disease treatment with controlled wireless energy supply |
US6482145B1 (en) * | 2000-02-14 | 2002-11-19 | Obtech Medical Ag | Hydraulic anal incontinence treatment |
US6453907B1 (en) * | 1999-08-12 | 2002-09-24 | Obtech Medical Ag | Food intake restriction with energy transfer device |
US6454699B1 (en) * | 2000-02-11 | 2002-09-24 | Obtech Medical Ag | Food intake restriction with controlled wireless energy supply |
US6461292B1 (en) * | 1999-08-12 | 2002-10-08 | Obtech Medical Ag | Anal incontinence treatment with wireless energy supply |
US6454701B1 (en) * | 1999-08-12 | 2002-09-24 | Obtech Medical Ag | Heartburn and reflux disease treatment apparatus with energy transfer device |
WO2001054615A2 (en) * | 2000-01-25 | 2001-08-02 | Harridan Medical | Device for preventing fecal incontinence |
US6454700B1 (en) * | 2000-02-09 | 2002-09-24 | Obtech Medical Ag | Heartburn and reflux disease treatment apparatus with wireless energy supply |
US6470892B1 (en) * | 2000-02-10 | 2002-10-29 | Obtech Medical Ag | Mechanical heartburn and reflux treatment |
US6463935B1 (en) * | 2000-02-10 | 2002-10-15 | Obtech Medical Ag | Controlled heartburn and reflux disease treatment |
BR0108223B1 (en) | 2000-02-10 | 2009-08-11 | mechanical apparatus for the treatment of impotence. | |
US6450946B1 (en) * | 2000-02-11 | 2002-09-17 | Obtech Medical Ag | Food intake restriction with wireless energy transfer |
ATE380006T1 (en) | 2000-02-11 | 2007-12-15 | Potencia Medical Ag | CONTROLLED IMPOTENCY TREATMENT |
MX340163B (en) | 2000-02-11 | 2016-06-29 | Potentica Ag | Impotence treatment apparatus with energy transforming means. |
US6475136B1 (en) * | 2000-02-14 | 2002-11-05 | Obtech Medical Ag | Hydraulic heartburn and reflux treatment |
DE60111019T2 (en) | 2000-02-14 | 2006-05-11 | Potencia Medical Ag | PROSTHESIS |
US20030100929A1 (en) | 2000-02-14 | 2003-05-29 | Peter Forsell | Controlled penile prosthesis |
BR0108307B1 (en) | 2000-02-14 | 2009-12-01 | Prosthesis apparatus for the treatment of male sexual impotence with wireless power supply device. | |
US6638211B2 (en) * | 2000-07-05 | 2003-10-28 | Mentor Corporation | Method for treating urinary incontinence in women and implantable device intended to correct urinary incontinence |
FR2811218B1 (en) | 2000-07-05 | 2003-02-28 | Patrice Suslian | IMPLANTABLE DEVICE FOR CORRECTING URINARY INCONTINENCE |
WO2002011696A2 (en) * | 2000-08-08 | 2002-02-14 | Ev & M | Active tissue augmentation materials and method |
US7025063B2 (en) * | 2000-09-07 | 2006-04-11 | Ams Research Corporation | Coated sling material |
US6527701B1 (en) * | 2000-09-29 | 2003-03-04 | Precision Medical Devices, Inc. | Body fluid flow control device |
US7011621B2 (en) * | 2000-09-29 | 2006-03-14 | Precision Medical Devices, Inc. | Body fluid flow control method and device |
US20060205995A1 (en) | 2000-10-12 | 2006-09-14 | Gyne Ideas Limited | Apparatus and method for treating female urinary incontinence |
GB0025068D0 (en) | 2000-10-12 | 2000-11-29 | Browning Healthcare Ltd | Apparatus and method for treating female urinary incontinence |
US8167785B2 (en) | 2000-10-12 | 2012-05-01 | Coloplast A/S | Urethral support system |
US6432038B1 (en) | 2001-02-15 | 2002-08-13 | Ramesh Bakane | Artificial urinary sphincter |
GB0108088D0 (en) | 2001-03-30 | 2001-05-23 | Browning Healthcare Ltd | Surgical implant |
WO2003043534A2 (en) * | 2001-11-20 | 2003-05-30 | Jocham, Dieter | Closing system and electronic control method |
WO2003075256A1 (en) * | 2002-03-05 | 2003-09-12 | Nec Corporation | Image display and its control method |
US20050197715A1 (en) * | 2002-04-26 | 2005-09-08 | Torax Medical, Inc. | Methods and apparatus for implanting devices into non-sterile body lumens or organs |
US7445010B2 (en) * | 2003-01-29 | 2008-11-04 | Torax Medical, Inc. | Use of magnetic implants to treat issue structures |
US7695427B2 (en) * | 2002-04-26 | 2010-04-13 | Torax Medical, Inc. | Methods and apparatus for treating body tissue sphincters and the like |
US7497822B1 (en) | 2003-04-10 | 2009-03-03 | Torax Medical, Inc. | Stomach reduction methods and apparatus |
US9427301B2 (en) * | 2002-07-29 | 2016-08-30 | Peter Forsell | Durable implant |
US20040034275A1 (en) * | 2002-07-29 | 2004-02-19 | Peter Forsell | Multi-material incontinence treatment constriction device |
US20040133219A1 (en) * | 2002-07-29 | 2004-07-08 | Peter Forsell | Multi-material constriction device for forming stoma opening |
ATE450228T1 (en) * | 2002-07-29 | 2009-12-15 | Potentica Ag | MULTIPLE MATERIAL PENIS CONSTRICTION DEVICE |
AU2003269934A1 (en) | 2002-08-02 | 2004-02-23 | C.R. Bard, Inc. | Self anchoring sling and introducer system |
US7338433B2 (en) | 2002-08-13 | 2008-03-04 | Allergan, Inc. | Remotely adjustable gastric banding method |
EP2181655B1 (en) | 2002-08-28 | 2016-12-07 | Apollo Endosurgery, Inc. | Fatigue-restistant gastric banding device |
US7972346B2 (en) * | 2002-09-04 | 2011-07-05 | Allergan Medical S.A. | Telemetrically controlled band for regulating functioning of a body organ or duct, and methods of making, implantation and use |
EP1396243B1 (en) * | 2002-09-04 | 2007-08-15 | Endoart S.A. | Surgical ring with remote control system for reversible variation of diameter |
US7901419B2 (en) * | 2002-09-04 | 2011-03-08 | Allergan, Inc. | Telemetrically controlled band for regulating functioning of a body organ or duct, and methods of making, implantation and use |
EP1396242B1 (en) * | 2002-09-04 | 2007-11-14 | Endoart S.A. | Closure system for surgical ring |
DE60312563T2 (en) * | 2003-01-31 | 2007-11-22 | Instant Communication Ag | ELECTRICALLY OPERATED DEVICE FOR IMPOTENCE TREATMENT |
WO2004066885A1 (en) * | 2003-01-31 | 2004-08-12 | Potencia Medical Ag | Electrically operable incontinence treatment apparatus |
GB0307082D0 (en) | 2003-03-27 | 2003-04-30 | Gyne Ideas Ltd | Drug delivery device and method |
CA2520818A1 (en) | 2003-03-28 | 2004-10-28 | Analytic Biosurgical Solutions Abiss | Implant for treatment of a rectocele and device for placement of said implant |
US7494495B2 (en) | 2003-03-28 | 2009-02-24 | Coloplast A/S | Method and implant for curing cystocele |
FR2855744B1 (en) * | 2003-06-04 | 2006-04-14 | Cie Euro Etude Rech Paroscopie | SURGICAL RING WITH IMPROVED CLOSURE SYSTEM |
US7632291B2 (en) | 2003-06-13 | 2009-12-15 | Trivascular2, Inc. | Inflatable implant |
US7201757B2 (en) * | 2003-06-20 | 2007-04-10 | Enteromedics Inc. | Gastro-esophageal reflux disease (GERD) treatment method and apparatus |
EP2311520B1 (en) * | 2003-09-15 | 2014-12-03 | Apollo Endosurgery, Inc. | Implantable device fastening system |
ES2399951T3 (en) | 2004-01-23 | 2013-04-04 | Allergan, Inc. | Adjustable gastric band of a piece that can be fixed releasably |
ATE489897T1 (en) * | 2004-01-23 | 2010-12-15 | Allergan Inc | FASTENING SYSTEM FOR AN IMPLANTABLE DEVICE AND METHOD OF USE |
EP2145610A1 (en) | 2004-03-08 | 2010-01-20 | Allergan Medical S.A. | Closure system for tubular organs |
ES2368149T3 (en) | 2004-03-18 | 2011-11-14 | Allergan, Inc. | APPARATUS FOR ADJUSTMENT OF THE VOLUME OF INTRAGASTRIC BALLOONS. |
GB0411360D0 (en) | 2004-05-21 | 2004-06-23 | Mpathy Medical Devices Ltd | Implant |
US7955357B2 (en) | 2004-07-02 | 2011-06-07 | Ellipse Technologies, Inc. | Expandable rod system to treat scoliosis and method of using the same |
US20060173468A1 (en) * | 2005-01-28 | 2006-08-03 | Marc Simmon | Obturator introducer with snare |
US8251888B2 (en) | 2005-04-13 | 2012-08-28 | Mitchell Steven Roslin | Artificial gastric valve |
US8333777B2 (en) | 2005-04-22 | 2012-12-18 | Benvenue Medical, Inc. | Catheter-based tissue remodeling devices and methods |
ATE489052T1 (en) * | 2005-05-18 | 2010-12-15 | Gt Urological Llc | ELUTION OF ACTIVE SUBSTANCES FOR IMPLANTABLE INCONTINENCE DEVICES |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
EP1912590A1 (en) | 2005-07-26 | 2008-04-23 | AMS Research Corporation | Methods and systems for treatment of prolapse |
AU2006275350A1 (en) * | 2005-08-04 | 2007-02-08 | C.R. Bard, Inc. | Pelvic implant systems and methods |
CA2617317A1 (en) * | 2005-08-04 | 2007-02-15 | C.R. Bard, Inc. | Systems for introducing implants |
ES2470338T3 (en) | 2005-11-14 | 2014-06-23 | C.R. Bard, Inc. | Sling anchor system |
US7798954B2 (en) | 2006-01-04 | 2010-09-21 | Allergan, Inc. | Hydraulic gastric band with collapsible reservoir |
US8043206B2 (en) | 2006-01-04 | 2011-10-25 | Allergan, Inc. | Self-regulating gastric band with pressure data processing |
WO2007109062A2 (en) * | 2006-03-15 | 2007-09-27 | C.R. Bard, Inc. | Implants for the treatment of pelvic floor disorders |
AU2007253683B2 (en) | 2006-05-19 | 2012-12-06 | Boston Scientific Scimed, Inc. | Method and articles for treatment of stress urinary incontinence |
US20070288033A1 (en) | 2006-06-09 | 2007-12-13 | Allergan, Inc. | Intragastric balloon retrieval mechanisms |
CN101500507B (en) | 2006-06-16 | 2013-09-25 | Ams研究公司 | Surgical implants, tools for treating pelvic conditions |
EP2049039A2 (en) | 2006-06-22 | 2009-04-22 | AMS Research Corporation | Adjustable tension incontinence sling assemblies |
WO2008033950A2 (en) | 2006-09-13 | 2008-03-20 | C. R. Bard, Inc. | Urethral support system |
US9326877B2 (en) * | 2006-09-29 | 2016-05-03 | Apollo Endosurgery, Inc. | Apparatus and method for intragastric balloon with in situ adjustment means |
US8246533B2 (en) | 2006-10-20 | 2012-08-21 | Ellipse Technologies, Inc. | Implant system with resonant-driven actuator |
US11259924B2 (en) | 2006-12-05 | 2022-03-01 | Valtech Cardio Ltd. | Implantation of repair devices in the heart |
US9883943B2 (en) | 2006-12-05 | 2018-02-06 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
EP2124831B1 (en) | 2007-03-15 | 2016-07-06 | Ortho-Space Ltd. | Prosthetic devices |
US8443808B2 (en) * | 2007-03-19 | 2013-05-21 | Hologic, Inc. | Methods and apparatus for occlusion of body lumens |
US20080255601A1 (en) * | 2007-04-13 | 2008-10-16 | Allergan, Inc. | Apparatus and method for remote deflation of intragastric balloon |
WO2008134064A1 (en) * | 2007-04-28 | 2008-11-06 | The Board Of Trustees Of The Leland Stanford Junior University | Dynamic and adjustable support devices |
US20090012542A1 (en) * | 2007-07-03 | 2009-01-08 | Synecor, Llc | Satiation devices and methods for controlling obesity |
US8007429B2 (en) * | 2007-07-05 | 2011-08-30 | Gt Urological, Llc | Vessel occlusive device and method of occluding a vessel |
JP2010536419A (en) * | 2007-08-14 | 2010-12-02 | カラント, インコーポレイテッド | Method and apparatus for supporting, raising or compressing a structure |
US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
US8226701B2 (en) | 2007-09-26 | 2012-07-24 | Trivascular, Inc. | Stent and delivery system for deployment thereof |
EP2194921B1 (en) | 2007-10-04 | 2018-08-29 | TriVascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
HRP20220513T3 (en) | 2007-10-11 | 2022-06-10 | Implantica Patent Ltd. | Apparatus for treating female sexual dysfunction |
US8696543B2 (en) * | 2007-10-11 | 2014-04-15 | Kirk Promotion Ltd. | Method for controlling flow of intestinal contents in a patient's intestines |
WO2009048391A2 (en) | 2007-10-11 | 2009-04-16 | Milux Holding Sa | Apparatus for controlling flow of intestinal contents in a patient's intestines |
EP2211772B1 (en) | 2007-10-11 | 2020-03-11 | Implantica Patent Ltd. | Apparatus for controlling flow of urine in bladder or urethra |
JP5400051B2 (en) * | 2007-10-11 | 2014-01-29 | ミルックス・ホールディング・エスエイ | A device that controls the flow of sperm in the fallopian tube |
US8795153B2 (en) | 2007-10-11 | 2014-08-05 | Peter Forsell | Method for treating female sexual dysfunction |
US8206280B2 (en) | 2007-11-13 | 2012-06-26 | C. R. Bard, Inc. | Adjustable tissue support member |
US8328861B2 (en) | 2007-11-16 | 2012-12-11 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
US8083789B2 (en) | 2007-11-16 | 2011-12-27 | Trivascular, Inc. | Securement assembly and method for expandable endovascular device |
US8961448B2 (en) * | 2008-01-28 | 2015-02-24 | Peter Forsell | Implantable drainage device |
US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
US11202707B2 (en) | 2008-03-25 | 2021-12-21 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant system |
US9023063B2 (en) | 2008-04-17 | 2015-05-05 | Apollo Endosurgery, Inc. | Implantable access port device having a safety cap |
MX2010011367A (en) | 2008-04-17 | 2010-11-12 | Allergan Inc | Implantable access port device and attachment system. |
WO2009152122A1 (en) * | 2008-06-11 | 2009-12-17 | Allergan, Inc. | Implantable pump system |
US8727963B2 (en) | 2008-07-31 | 2014-05-20 | Ams Research Corporation | Methods and implants for treating urinary incontinence |
WO2010027796A1 (en) | 2008-08-25 | 2010-03-11 | Ams Research Corporation | Minimally invasive implant and method |
US9017243B2 (en) | 2008-08-25 | 2015-04-28 | Ams Research Corporation | Minimally invasive implant and method |
WO2010042493A1 (en) | 2008-10-06 | 2010-04-15 | Allergan, Inc. | Mechanical gastric band with cushions |
WO2010042032A1 (en) | 2008-10-10 | 2010-04-15 | Milux Holding S.A. | Fastening means for implantable medcial control assembly |
ES2877781T3 (en) * | 2008-10-10 | 2021-11-17 | Implantica Patent Ltd | A device for temporary male contraception |
EP2349170B1 (en) | 2008-10-10 | 2023-09-27 | Implantica Patent Ltd. | Apparatus for the treatment of female sexual dysfunction |
EP2349096B1 (en) | 2008-10-10 | 2021-01-27 | MedicalTree Patent Ltd. | An improved artificial valve |
US11628053B2 (en) * | 2008-10-10 | 2023-04-18 | Peter Forsell | Variable sling for urinary continence |
EP3689318A1 (en) | 2008-10-10 | 2020-08-05 | MedicalTree Patent Ltd. | Heart help device and system |
US20100185049A1 (en) | 2008-10-22 | 2010-07-22 | Allergan, Inc. | Dome and screw valves for remotely adjustable gastric banding systems |
US8241351B2 (en) | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
US8926696B2 (en) | 2008-12-22 | 2015-01-06 | Valtech Cardio, Ltd. | Adjustable annuloplasty devices and adjustment mechanisms therefor |
US8715342B2 (en) | 2009-05-07 | 2014-05-06 | Valtech Cardio, Ltd. | Annuloplasty ring with intra-ring anchoring |
US8696542B2 (en) * | 2008-12-23 | 2014-04-15 | Ams Research Corporation | Biased artificial sphincter cuff |
US9622792B2 (en) | 2009-04-29 | 2017-04-18 | Nuvasive Specialized Orthopedics, Inc. | Interspinous process device and method |
US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
US10952836B2 (en) | 2009-07-17 | 2021-03-23 | Peter Forsell | Vaginal operation method for the treatment of urinary incontinence in women |
US9949812B2 (en) | 2009-07-17 | 2018-04-24 | Peter Forsell | Vaginal operation method for the treatment of anal incontinence in women |
US8715158B2 (en) | 2009-08-26 | 2014-05-06 | Apollo Endosurgery, Inc. | Implantable bottom exit port |
US8506532B2 (en) | 2009-08-26 | 2013-08-13 | Allergan, Inc. | System including access port and applicator tool |
US8708979B2 (en) | 2009-08-26 | 2014-04-29 | Apollo Endosurgery, Inc. | Implantable coupling device |
US8277426B2 (en) | 2009-09-30 | 2012-10-02 | Wilcox Heather J | Male urinary incontinence device |
US9180007B2 (en) | 2009-10-29 | 2015-11-10 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of an adjustable implant |
US9364308B2 (en) | 2009-12-30 | 2016-06-14 | Astora Women's Health, Llc | Implant systems with tensioning feedback |
CA2785560A1 (en) | 2009-12-30 | 2011-07-07 | Ams Research Corporation | Elongate implant system and method for treating pelvic conditions |
US8882728B2 (en) | 2010-02-10 | 2014-11-11 | Apollo Endosurgery, Inc. | Implantable injection port |
US20110201874A1 (en) * | 2010-02-12 | 2011-08-18 | Allergan, Inc. | Remotely adjustable gastric banding system |
US8678993B2 (en) * | 2010-02-12 | 2014-03-25 | Apollo Endosurgery, Inc. | Remotely adjustable gastric banding system |
US8758221B2 (en) | 2010-02-24 | 2014-06-24 | Apollo Endosurgery, Inc. | Source reservoir with potential energy for remotely adjustable gastric banding system |
US8764624B2 (en) | 2010-02-25 | 2014-07-01 | Apollo Endosurgery, Inc. | Inductively powered remotely adjustable gastric banding system |
US8840541B2 (en) | 2010-02-25 | 2014-09-23 | Apollo Endosurgery, Inc. | Pressure sensing gastric banding system |
US8939888B2 (en) | 2010-04-28 | 2015-01-27 | Apollo Endosurgery, Inc. | Method and system for determining the pressure of a fluid in a syringe, an access port, a catheter, and a gastric band |
US9028394B2 (en) | 2010-04-29 | 2015-05-12 | Apollo Endosurgery, Inc. | Self-adjusting mechanical gastric band |
US9044298B2 (en) | 2010-04-29 | 2015-06-02 | Apollo Endosurgery, Inc. | Self-adjusting gastric band |
US20110270024A1 (en) | 2010-04-29 | 2011-11-03 | Allergan, Inc. | Self-adjusting gastric band having various compliant components |
US20110270025A1 (en) | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Remotely powered remotely adjustable gastric band system |
US8992415B2 (en) | 2010-04-30 | 2015-03-31 | Apollo Endosurgery, Inc. | Implantable device to protect tubing from puncture |
US20110270021A1 (en) | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Electronically enhanced access port for a fluid filled implant |
US9226840B2 (en) | 2010-06-03 | 2016-01-05 | Apollo Endosurgery, Inc. | Magnetically coupled implantable pump system and method |
US8517915B2 (en) | 2010-06-10 | 2013-08-27 | Allergan, Inc. | Remotely adjustable gastric banding system |
EP2401984A1 (en) * | 2010-07-02 | 2012-01-04 | MyoPowers Medical Technologies SA | Medical device comprising an artificial contractile structure |
EP2401985A1 (en) * | 2010-07-02 | 2012-01-04 | MyoPowers Medical Technologies SA | Medical device comprising an artificial contractile structure |
US20120041258A1 (en) | 2010-08-16 | 2012-02-16 | Allergan, Inc. | Implantable access port system |
US8698373B2 (en) | 2010-08-18 | 2014-04-15 | Apollo Endosurgery, Inc. | Pare piezo power with energy recovery |
US9211207B2 (en) | 2010-08-18 | 2015-12-15 | Apollo Endosurgery, Inc. | Power regulated implant |
US20120059216A1 (en) | 2010-09-07 | 2012-03-08 | Allergan, Inc. | Remotely adjustable gastric banding system |
US20120065460A1 (en) | 2010-09-14 | 2012-03-15 | Greg Nitka | Implantable access port system |
ES2566498T3 (en) | 2010-10-18 | 2016-04-13 | Apollo Endosurgery, Inc. | Intragastric implants with duodenal anchors |
US8870966B2 (en) | 2010-10-18 | 2014-10-28 | Apollo Endosurgery, Inc. | Intragastric balloon for treating obesity |
US9463107B2 (en) | 2010-10-18 | 2016-10-11 | Apollo Endosurgery, Inc. | Variable size intragastric implant devices |
EP2629715B1 (en) | 2010-10-18 | 2016-01-06 | Apollo Endosurgery, Inc. | Reactive intragastric implant devices |
US9498365B2 (en) | 2010-10-19 | 2016-11-22 | Apollo Endosurgery, Inc. | Intragastric implants with multiple fluid chambers |
ES2593753T3 (en) | 2010-10-19 | 2016-12-13 | Apollo Endosurgery, Inc. | Duodenal sleeve with anchor without perforation |
US9398969B2 (en) | 2010-10-19 | 2016-07-26 | Apollo Endosurgery, Inc. | Upper stomach gastric implants |
US8920447B2 (en) | 2010-10-19 | 2014-12-30 | Apollo Endosurgery, Inc. | Articulated gastric implant clip |
US8864840B2 (en) | 2010-10-19 | 2014-10-21 | Apollo Endosurgery, Inc. | Intragastric implants with collapsible frames |
US9198790B2 (en) | 2010-10-19 | 2015-12-01 | Apollo Endosurgery, Inc. | Upper stomach gastric implants |
US8961393B2 (en) | 2010-11-15 | 2015-02-24 | Apollo Endosurgery, Inc. | Gastric band devices and drive systems |
US9572648B2 (en) | 2010-12-21 | 2017-02-21 | Justin M. Crank | Implantable slings and anchor systems |
EP2665448A4 (en) * | 2011-01-18 | 2017-08-02 | GT Urological, LLC | Vessel occlusive device and method of occluding a vessel |
US9622848B2 (en) | 2011-02-23 | 2017-04-18 | Boston Scientific Scimed, Inc. | Urethral stent system and method |
US8888732B2 (en) | 2011-03-11 | 2014-11-18 | Apollo Endosurgery, Inc. | Intraluminal sleeve with active agents |
US8808162B2 (en) | 2011-03-28 | 2014-08-19 | Ams Research Corporation | Implants, tools, and methods for treatment of pelvic conditions |
US9750590B2 (en) | 2011-03-28 | 2017-09-05 | Andrew P. VanDeWeghe | Implants, tools, and methods for treatment of pelvic conditions |
US9492259B2 (en) | 2011-03-30 | 2016-11-15 | Astora Women's Health, Llc | Expandable implant system |
US8725435B2 (en) | 2011-04-13 | 2014-05-13 | Apollo Endosurgery, Inc. | Syringe-based leak detection system |
US8821373B2 (en) | 2011-05-10 | 2014-09-02 | Apollo Endosurgery, Inc. | Directionless (orientation independent) needle injection port |
US10792152B2 (en) | 2011-06-23 | 2020-10-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US10058240B2 (en) | 2011-06-29 | 2018-08-28 | Boston Scientific Scimed, Inc. | Systems, implants, tools, and methods for treatments of pelvic conditions |
US9351723B2 (en) | 2011-06-30 | 2016-05-31 | Astora Women's Health, Llc | Implants, tools, and methods for treatments of pelvic conditions |
US9414903B2 (en) | 2011-07-22 | 2016-08-16 | Astora Women's Health, Llc | Pelvic implant system and method |
EP2734148B1 (en) | 2011-07-22 | 2019-06-05 | Boston Scientific Scimed, Inc. | Pelvic implant system |
US9492191B2 (en) | 2011-08-04 | 2016-11-15 | Astora Women's Health, Llc | Tools and methods for treatment of pelvic conditions |
US20130035555A1 (en) | 2011-08-05 | 2013-02-07 | Alexander James A | Systems, implants, tools, and methods for treatment of pelvic conditions |
US8801597B2 (en) | 2011-08-25 | 2014-08-12 | Apollo Endosurgery, Inc. | Implantable access port with mesh attachment rivets |
US10098721B2 (en) | 2011-09-01 | 2018-10-16 | Boston Scientific Scimed, Inc. | Pelvic implant needle system and method |
FR2979544B1 (en) * | 2011-09-02 | 2014-10-24 | Perouse Medical | NECESSARY FOR MANEUVERING AN ELEMENT PRESENT IN THE BODY OF A PATIENT, COMPRISING AN IMPLANTABLE CHAMBER |
US10265152B2 (en) | 2011-10-13 | 2019-04-23 | Boston Scientific Scimed, Inc. | Pelvic implant sizing systems and methods |
US9289307B2 (en) | 2011-10-18 | 2016-03-22 | Ortho-Space Ltd. | Prosthetic devices and methods for using same |
US9199069B2 (en) | 2011-10-20 | 2015-12-01 | Apollo Endosurgery, Inc. | Implantable injection port |
EP2775896B1 (en) | 2011-11-08 | 2020-01-01 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
US8858421B2 (en) | 2011-11-15 | 2014-10-14 | Apollo Endosurgery, Inc. | Interior needle stick guard stems for tubes |
US9089395B2 (en) | 2011-11-16 | 2015-07-28 | Appolo Endosurgery, Inc. | Pre-loaded septum for use with an access port |
US8876694B2 (en) | 2011-12-07 | 2014-11-04 | Apollo Endosurgery, Inc. | Tube connector with a guiding tip |
EP2790609B1 (en) | 2011-12-12 | 2015-09-09 | David Alon | Heart valve repair device |
US8961394B2 (en) | 2011-12-20 | 2015-02-24 | Apollo Endosurgery, Inc. | Self-sealing fluid joint for use with a gastric band |
US9192458B2 (en) | 2012-02-09 | 2015-11-24 | Ams Research Corporation | Implants, tools, and methods for treatments of pelvic conditions |
FR2988996B1 (en) * | 2012-04-06 | 2015-01-23 | Uromems | METHOD AND DEVICE FOR CONTROLLING AN IMPLANTABLE DEVICE |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
WO2013158586A1 (en) | 2012-04-16 | 2013-10-24 | Gt Urological, Llc | Hydraulic urethral occlusive device |
CN108635082B (en) | 2012-05-31 | 2021-07-09 | 标枪医疗有限公司 | Systems, methods, and devices for embolic protection |
WO2014052818A1 (en) | 2012-09-29 | 2014-04-03 | Mitralign, Inc. | Plication lock delivery system and method of use thereof |
GB2507053A (en) * | 2012-10-16 | 2014-04-23 | Jonathan Featherstone | Nephroureterectomy apparatus |
WO2014064694A2 (en) | 2012-10-23 | 2014-05-01 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
WO2014064695A2 (en) | 2012-10-23 | 2014-05-01 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
US9730793B2 (en) | 2012-12-06 | 2017-08-15 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
ES2895968T3 (en) | 2013-01-18 | 2022-02-23 | Javelin Medical Ltd | Monofilament implants and systems for supplying the same |
EP2961351B1 (en) | 2013-02-26 | 2018-11-28 | Mitralign, Inc. | Devices for percutaneous tricuspid valve repair |
US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
US9724195B2 (en) | 2013-03-15 | 2017-08-08 | Mitralign, Inc. | Translation catheters and systems |
FR3005846B1 (en) * | 2013-05-21 | 2018-03-23 | Uromems | METHOD AND DEVICE FOR DETECTING THE ATROPHY OF A NATURAL CONDUIT SURROUNDED BY AN OCCLUSION SYSTEM |
US20140378746A1 (en) | 2013-06-19 | 2014-12-25 | Mahdi Mohammadi | Artificial sphincter |
CN105530890A (en) | 2013-08-06 | 2016-04-27 | Gt泌尿学公司 | Hydraulic urethral occlusive device |
CN103393480B (en) * | 2013-08-15 | 2015-04-01 | 上海交通大学 | Artificial anal sphincter prosthesis based on elastic contraction and release |
US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
US9592110B1 (en) | 2013-12-06 | 2017-03-14 | Javelin Medical, Ltd. | Systems and methods for implant delivery |
JP6429409B2 (en) | 2014-02-07 | 2018-11-28 | マイオパワーズ メディカル テクノロジーズ フランス エスエーエスMyoPowers Medical Technologies France SAS | Medical device with artificial contraction structure |
EP4331503A3 (en) | 2014-10-14 | 2024-06-05 | Edwards Lifesciences Innovation (Israel) Ltd. | Leaflet-restraining techniques |
WO2016110848A1 (en) * | 2015-01-06 | 2016-07-14 | Javelin Medical Ltd. | System and method for embolic protection |
US20160256269A1 (en) | 2015-03-05 | 2016-09-08 | Mitralign, Inc. | Devices for treating paravalvular leakage and methods use thereof |
JP6495062B2 (en) * | 2015-03-20 | 2019-04-03 | 国立大学法人東北大学 | Medical active clip |
SG10202010021SA (en) | 2015-04-30 | 2020-11-27 | Valtech Cardio Ltd | Annuloplasty technologies |
WO2017046647A1 (en) | 2015-09-18 | 2017-03-23 | Ortho-Space Ltd. | Intramedullary fixated subacromial spacers |
EP3361960B1 (en) | 2015-10-16 | 2023-05-10 | NuVasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
WO2017117370A2 (en) | 2015-12-30 | 2017-07-06 | Mitralign, Inc. | System and method for reducing tricuspid regurgitation |
US10702274B2 (en) | 2016-05-26 | 2020-07-07 | Edwards Lifesciences Corporation | Method and system for closing left atrial appendage |
GB201611910D0 (en) | 2016-07-08 | 2016-08-24 | Valtech Cardio Ltd | Adjustable annuloplasty device with alternating peaks and troughs |
CN109890302B (en) | 2016-10-21 | 2022-10-21 | 贾夫林医疗有限公司 | Systems, methods, and devices for embolic protection |
WO2018138561A1 (en) | 2017-01-30 | 2018-08-02 | Ortho-Space Ltd. | Processing machine and methods for processing dip-molded articles |
US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
US10835221B2 (en) | 2017-11-02 | 2020-11-17 | Valtech Cardio, Ltd. | Implant-cinching devices and systems |
US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
CN111757715B (en) | 2017-11-30 | 2024-01-19 | 淼保尔斯医疗科技法国股份公司 | Artificial contractible structure and medical device comprising such an artificial contractible structure |
CA3086884A1 (en) | 2018-01-24 | 2019-08-01 | Valtech Cardio, Ltd. | Contraction of an annuloplasty structure |
WO2019145941A1 (en) | 2018-01-26 | 2019-08-01 | Valtech Cardio, Ltd. | Techniques for facilitating heart valve tethering and chord replacement |
MX2020013973A (en) | 2018-07-12 | 2021-06-15 | Valtech Cardio Ltd | Annuloplasty systems and locking tools therefor. |
AU2020375903A1 (en) | 2019-10-29 | 2021-12-23 | Edwards Lifesciences Innovation (Israel) Ltd. | Annuloplasty and tissue anchor technologies |
US12023247B2 (en) | 2020-05-20 | 2024-07-02 | Edwards Lifesciences Corporation | Reducing the diameter of a cardiac valve annulus with independent control over each of the anchors that are launched into the annulus |
US11583380B1 (en) | 2022-06-16 | 2023-02-21 | Magnetic Five LLC | Male continence device |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3749098A (en) * | 1970-04-07 | 1973-07-31 | Anvar | Apparatus for intracorporeal control,in particular of the cross-section of an organic vessel or duct |
US4118805A (en) * | 1977-02-28 | 1978-10-10 | Codman & Shurtleff, Inc. | Artificial sphincter |
US4453536A (en) * | 1980-11-03 | 1984-06-12 | Abild Robert N | Body channel occluder |
US5704893A (en) * | 1994-07-11 | 1998-01-06 | Dacomed Corportion | Vessel occlusive apparatus and method |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3810259A (en) * | 1971-01-25 | 1974-05-14 | Fairchild Industries | Implantable urinary control apparatus |
US3744063A (en) * | 1971-10-12 | 1973-07-10 | Kendall & Co | Artifical sphincter for controlling urinary incontinence |
US3863622A (en) * | 1973-01-09 | 1975-02-04 | Robert Enno Buuck | Incontinence system and methods of implanting and using same |
US4417567A (en) * | 1981-08-12 | 1983-11-29 | Medical Engineering Corporation | Artificial sphincter |
US4474187A (en) * | 1981-11-05 | 1984-10-02 | Dacomed Corporation | Threshold penile rigidity measuring device |
US4911176A (en) * | 1981-11-05 | 1990-03-27 | Dacomed Corporation | Threshold penile rigidity measuring device |
US4731083A (en) * | 1982-09-21 | 1988-03-15 | The Johns Hopkins University | Manually actuated hydraulic sphincter |
US4784660A (en) * | 1982-09-21 | 1988-11-15 | The Johns Hopkins University | Manually actuated hydraulic sphincter having a mechanical actuator |
US4571749A (en) * | 1982-09-21 | 1986-02-25 | The Johns Hopkins University | Manually actuated hydraulic sphincter |
US4606353A (en) * | 1983-06-13 | 1986-08-19 | Dacomed Corporation | Nocturnal penile tumescence and rigidity monitor and method |
US4515166A (en) * | 1983-06-13 | 1985-05-07 | Dacomed Corporation | Nocturnal penile tumescence and rigidity monitor |
US4766909A (en) * | 1984-03-19 | 1988-08-30 | Dacomed Corporation | Threshold penile rigidity measuring device |
US4584990A (en) * | 1984-10-02 | 1986-04-29 | Habley Medical Technology Corporation | Prosthetic sphincter having a diametric occlusion geometry |
US4848631A (en) * | 1986-04-07 | 1989-07-18 | Joseph Gentile | Slide block feed apparatus for a press utilizing an oscillating cam |
US4829990A (en) * | 1987-06-25 | 1989-05-16 | Thueroff Joachim | Implantable hydraulic penile erector |
US5184629A (en) * | 1989-03-20 | 1993-02-09 | Dacomed Corporation | Male urinary anti-incontinence device and method |
US4958630A (en) * | 1989-10-06 | 1990-09-25 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating impotence |
-
1998
- 1998-06-09 US US09/094,055 patent/US6074341A/en not_active Expired - Lifetime
-
1999
- 1999-06-08 CA CA002334387A patent/CA2334387A1/en not_active Abandoned
- 1999-06-08 AU AU45483/99A patent/AU746023B2/en not_active Ceased
- 1999-06-08 WO PCT/US1999/012624 patent/WO1999063907A1/en not_active Application Discontinuation
- 1999-06-08 JP JP2000552983A patent/JP2002517277A/en active Pending
- 1999-06-08 CN CN99807156.0A patent/CN1305357A/en active Pending
- 1999-06-08 EP EP99928412A patent/EP1085841A1/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3749098A (en) * | 1970-04-07 | 1973-07-31 | Anvar | Apparatus for intracorporeal control,in particular of the cross-section of an organic vessel or duct |
US4118805A (en) * | 1977-02-28 | 1978-10-10 | Codman & Shurtleff, Inc. | Artificial sphincter |
US4453536A (en) * | 1980-11-03 | 1984-06-12 | Abild Robert N | Body channel occluder |
US5704893A (en) * | 1994-07-11 | 1998-01-06 | Dacomed Corportion | Vessel occlusive apparatus and method |
Cited By (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1105073B2 (en) † | 1998-08-13 | 2013-09-18 | Obtech Medical GmbH | Food intake restriction device |
EP1554996B1 (en) * | 1998-08-13 | 2008-01-16 | Obtech Medical AG | Food intake restriction device |
US8932247B2 (en) | 1999-07-19 | 2015-01-13 | Apollo Endosurgery, Inc. | Flow control method and device |
US7128750B1 (en) | 1999-07-19 | 2006-10-31 | Endoart S.A. | Flow control method and device |
US8506517B2 (en) | 1999-07-19 | 2013-08-13 | Allergan, Inc. | Flow control method and device |
US8079974B2 (en) | 1999-07-19 | 2011-12-20 | Allergan, Inc. | Flow control method and device |
CN1698552B (en) * | 2000-02-10 | 2010-05-12 | 厄罗洛吉卡股份公司 | Controlled urinary incontinence treatment |
EP1582176A1 (en) * | 2000-02-10 | 2005-10-05 | Potencia Medical AG | Mechanical impotence treatment apparatus |
EP1598030A1 (en) * | 2000-02-10 | 2005-11-23 | Potencia Medical AG | Controlled urinary incontinence treatment |
EP1609440A1 (en) * | 2000-02-10 | 2005-12-28 | Potencia Medical AG | Anal incontinence treatment apparatus with controlled energy supply |
EP1568338A3 (en) * | 2000-02-10 | 2006-11-02 | Potencia Medical AG | Mechanical impotence treatment apparatus |
CN1720879B (en) * | 2000-02-10 | 2011-01-19 | 厄罗洛吉卡股份公司 | Urinary incontinence treatment with wireless energy supply. |
EP1284691B1 (en) * | 2000-02-11 | 2006-12-20 | Potencia Medical AG | Urinary incontinence treatment apparatus |
EP1253888B1 (en) * | 2000-02-11 | 2006-01-11 | Potencia Medical AG | Anal incontinence treatment apparatus |
EP3513769A1 (en) * | 2000-02-11 | 2019-07-24 | Implantica Patents Ltd | Urinary incontinence treatment apparatus |
EP1586283A2 (en) | 2000-02-11 | 2005-10-19 | Potencia Medical AG | Urinary incontinence treatment apparatus |
EP1586283A3 (en) * | 2000-02-11 | 2008-07-09 | Potencia Medical AG | Urinary incontinence treatment apparatus |
EP1792583A1 (en) * | 2000-02-11 | 2007-06-06 | Potencia Medical AG | Urinary incontinence treatment apparatus |
EP1759665A3 (en) * | 2000-02-11 | 2008-07-09 | Potencia Medical AG | Urinary incontinence treatment apparatus |
EP1257233A1 (en) * | 2000-02-24 | 2002-11-20 | BENDEREV, Theodore V. | Surgical monitor |
EP1257233A4 (en) * | 2000-02-24 | 2007-05-02 | Theodore V Benderev | Surgical monitor |
US7988616B2 (en) | 2002-10-01 | 2011-08-02 | Potencia Medical Ag | Implantable pump for operation of hydraulic implant |
US8821371B2 (en) | 2002-10-01 | 2014-09-02 | Potencia Medical Ag | Implantable pump for operation of hydraulic implant |
US10561498B2 (en) | 2005-03-17 | 2020-02-18 | Valtech Cardio, Ltd. | Mitral valve treatment techniques |
US9271857B2 (en) | 2006-10-20 | 2016-03-01 | Ellipse Technologies, Inc. | Adjustable implant and method of use |
US11234849B2 (en) | 2006-10-20 | 2022-02-01 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant and method of use |
US11672684B2 (en) | 2006-10-20 | 2023-06-13 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant and method of use |
US8715159B2 (en) | 2006-10-20 | 2014-05-06 | Ellipse Technologies, Inc. | Adjustable implant and method of use |
US10039661B2 (en) | 2006-10-20 | 2018-08-07 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant and method of use |
US9526650B2 (en) | 2006-10-20 | 2016-12-27 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant and method of use |
FR2917286A1 (en) * | 2007-06-15 | 2008-12-19 | Microval Sa | DEVICE FOR TENSIONING AN IMPLANT IN FLEXIBLE MATERIAL |
EP2002802A1 (en) * | 2007-06-15 | 2008-12-17 | Microval | Device for placing an implant made from flexible material under tension |
US9913774B2 (en) | 2007-10-11 | 2018-03-13 | Peter Forsell | Implantable device for external urinary control |
US8992409B2 (en) | 2007-10-11 | 2015-03-31 | Peter Forsell | Method for controlling flow in a bodily organ |
US9662117B2 (en) | 2007-10-11 | 2017-05-30 | Peter Forsell | Apparatus for controlling flow in a bodily organ |
US9351664B2 (en) | 2007-10-11 | 2016-05-31 | Peter Forsell | Implantable device for external urinary control |
US10349995B2 (en) | 2007-10-30 | 2019-07-16 | Nuvasive Specialized Orthopedics, Inc. | Skeletal manipulation method |
US11172972B2 (en) | 2007-10-30 | 2021-11-16 | Nuvasive Specialized Orthopedics, Inc. | Skeletal manipulation method |
US9060771B2 (en) | 2008-01-29 | 2015-06-23 | Peter Forsell | Method and instrument for treating obesity |
US10583234B2 (en) | 2008-10-10 | 2020-03-10 | Peter Forsell | Heart help device, system and method |
US11938318B2 (en) | 2008-10-10 | 2024-03-26 | Peter Forsell | Apparatus for temporary male contraception |
US8874215B2 (en) | 2008-10-10 | 2014-10-28 | Peter Forsell | System, an apparatus, and a method for treating a sexual dysfunctional female patient |
US9370656B2 (en) | 2008-10-10 | 2016-06-21 | Peter Forsell | System, an apparatus, and a method for treating a sexual dysfunctional female patient |
US10729470B2 (en) | 2008-11-10 | 2020-08-04 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US10350068B2 (en) | 2009-02-17 | 2019-07-16 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
US10517643B2 (en) | 2009-02-23 | 2019-12-31 | Nuvasive Specialized Orthopedics, Inc. | Non-invasive adjustable distraction system |
US10548729B2 (en) | 2009-05-04 | 2020-02-04 | Valtech Cardio, Ltd. | Deployment techniques for annuloplasty ring and over-wire rotation tool |
US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US10492909B2 (en) | 2009-12-02 | 2019-12-03 | Valtech Cardio, Ltd. | Tool for actuating an adjusting mechanism |
US10660675B2 (en) | 2010-06-30 | 2020-05-26 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10405891B2 (en) | 2010-08-09 | 2019-09-10 | Nuvasive Specialized Orthopedics, Inc. | Maintenance feature in magnetic implant |
US10646262B2 (en) | 2011-02-14 | 2020-05-12 | Nuvasive Specialized Orthopedics, Inc. | System and method for altering rotational alignment of bone sections |
US9918840B2 (en) | 2011-06-23 | 2018-03-20 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US10743794B2 (en) | 2011-10-04 | 2020-08-18 | Nuvasive Specialized Orthopedics, Inc. | Devices and methods for non-invasive implant length sensing |
US11123107B2 (en) | 2011-11-01 | 2021-09-21 | Nuvasive Specialized Orthopedics, Inc. | Adjustable magnetic devices and methods of using same |
US10349982B2 (en) | 2011-11-01 | 2019-07-16 | Nuvasive Specialized Orthopedics, Inc. | Adjustable magnetic devices and methods of using same |
US9775709B2 (en) | 2011-11-04 | 2017-10-03 | Valtech Cardio, Ltd. | Implant having multiple adjustable mechanisms |
US11191579B2 (en) | 2012-10-29 | 2021-12-07 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US11213330B2 (en) | 2012-10-29 | 2022-01-04 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US10751094B2 (en) | 2013-10-10 | 2020-08-25 | Nuvasive Specialized Orthopedics, Inc. | Adjustable spinal implant |
US10299793B2 (en) | 2013-10-23 | 2019-05-28 | Valtech Cardio, Ltd. | Anchor magazine |
US10265170B2 (en) | 2013-12-26 | 2019-04-23 | Valtech Cardio, Ltd. | Implantation of flexible implant |
US11246694B2 (en) | 2014-04-28 | 2022-02-15 | Nuvasive Specialized Orthopedics, Inc. | System for informational magnetic feedback in adjustable implants |
US11439449B2 (en) | 2014-12-26 | 2022-09-13 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for distraction |
US10271885B2 (en) | 2014-12-26 | 2019-04-30 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for distraction |
US10238427B2 (en) | 2015-02-19 | 2019-03-26 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for vertebral adjustment |
US11612416B2 (en) | 2015-02-19 | 2023-03-28 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for vertebral adjustment |
US12076051B2 (en) | 2015-02-19 | 2024-09-03 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for vertebral adjustment |
US10835290B2 (en) | 2015-12-10 | 2020-11-17 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
GB2545667A (en) * | 2015-12-21 | 2017-06-28 | Balatech Ltd | Flow control valves |
US10918425B2 (en) | 2016-01-28 | 2021-02-16 | Nuvasive Specialized Orthopedics, Inc. | System and methods for bone transport |
US10765504B2 (en) | 2017-12-01 | 2020-09-08 | C. R. Bard, Inc. | Adjustable vascular graft for custom inner diameter reduction and related methods |
US12097109B2 (en) | 2017-12-01 | 2024-09-24 | C. R. Bard, Inc. | Adjustable vascular graft for custom inner diameter reduction and related methods |
Also Published As
Publication number | Publication date |
---|---|
CA2334387A1 (en) | 1999-12-16 |
EP1085841A1 (en) | 2001-03-28 |
JP2002517277A (en) | 2002-06-18 |
US6074341A (en) | 2000-06-13 |
CN1305357A (en) | 2001-07-25 |
AU4548399A (en) | 1999-12-30 |
AU746023B2 (en) | 2002-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6074341A (en) | Vessel occlusive apparatus and method | |
EP0769928B1 (en) | Vessel occlusive apparatus | |
EP2170221B1 (en) | Vessel occlusive device and method of occluding a vessel | |
US6135945A (en) | Anti-incontinence device | |
US9675437B2 (en) | Management of urinary incontinence in females | |
US8753363B2 (en) | Vessel occlusive device and method of occluding a vessel | |
EP1587465B1 (en) | Incontinence treatment apparatus with connection device | |
US8876690B2 (en) | Devices, systems, and methods for deforming a body channel | |
US10729525B2 (en) | Devices, systems, and methods for deforming a body channel | |
US9301824B2 (en) | Hydraulic urethral occlusive device | |
US9597170B2 (en) | Hydraulic urethral occlusive device | |
US20160220341A1 (en) | Hydraulic urethral occlusive device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99807156.0 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 45483/99 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2334387 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2000 552983 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999928412 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999928412 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 45483/99 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999928412 Country of ref document: EP |